And so, in response to the current day problem with antibiotics, researchers from the University of Rockefeller have been working on a smarter way to fight bacteria using ‘programmable’ antibiotics which specifically targets the antibiotic resistance genes and cuts it out of the DNA sequence. By using the bacterial enzyme known as Cas9, the researchers were successful in getting it to target a particular DNA sequence and remove it from the bacteria. This new approach could reduce the risk of C. diff (which is an infection of the colon) and they were able to get Cas9 to target the specific sequenes by
And so, in response to the current day problem with antibiotics, researchers from the University of Rockefeller have been working on a smarter way to fight bacteria using ‘programmable’ antibiotics which specifically targets the antibiotic resistance genes and cuts it out of the DNA sequence. By using the bacterial enzyme known as Cas9, the researchers were successful in getting it to target a particular DNA sequence and remove it from the bacteria. This new approach could reduce the risk of C. diff (which is an infection of the colon) and they were able to get Cas9 to target the specific sequenes by